Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia cash
Cash and short-term investments held at the end of each period.
Liquidia's cash was $284.18M at Jun 30, 2026. For fiscal 2025 it was $190.68M, up 8.0% from the year before. The highest annual figure on record is $190.68M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.68M | +8.0% |
| FY2024 | Dec 31, 2024 | $176.48M | +110.9% |
| FY2023 | Dec 31, 2023 | $83.68M | -10.3% |
| FY2022 | Dec 31, 2022 | $93.28M | +62.2% |
| FY2021 | Dec 31, 2021 | $57.49M | -12.0% |
| FY2020 | Dec 31, 2020 | $65.32M | +17.1% |
| FY2019 | Dec 31, 2019 | $55.80M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $284.18M | +63.9% |
| Q1 FY2026 | Mar 31, 2026 | $222.79M | +31.2% |
| Q4 FY2025 | Dec 31, 2025 | $190.68M | +8.0% |
| Q3 FY2025 | Sep 30, 2025 | $157.50M | -22.9% |
| Q2 FY2025 | Jun 30, 2025 | $173.42M | +30.3% |
| Q1 FY2025 | Mar 31, 2025 | $169.76M | +7.5% |
| Q4 FY2024 | Dec 31, 2024 | $176.48M | +110.9% |
| Q3 FY2024 | Sep 30, 2024 | $204.37M | +168.1% |
| Q2 FY2024 | Jun 30, 2024 | $133.09M | +50.9% |
| Q1 FY2024 | Mar 31, 2024 | $157.86M | +67.2% |
| Q4 FY2023 | Dec 31, 2023 | $83.68M | -10.3% |
| Q3 FY2023 | Sep 30, 2023 | $76.23M | -22.5% |
| Q2 FY2023 | Jun 30, 2023 | $88.20M | -15.1% |
| Q1 FY2023 | Mar 31, 2023 | $94.41M | +63.4% |
| Q4 FY2022 | Dec 31, 2022 | $93.28M | +62.2% |
| Q3 FY2022 | Sep 30, 2022 | $98.32M | +53.5% |
| Q2 FY2022 | Jun 30, 2022 | $103.84M | +53.0% |
| Q1 FY2022 | Mar 31, 2022 | $57.79M | +7.7% |
| Q4 FY2021 | Dec 31, 2021 | $57.49M | -12.0% |
| Q3 FY2021 | Sep 30, 2021 | $64.05M | +14.8% |
| Q2 FY2021 | Jun 30, 2021 | $67.89M | – |
| Q1 FY2021 | Mar 31, 2021 | $53.64M | – |
| Q4 FY2020 | Dec 31, 2020 | $65.32M | – |
| Q4 FY2019 | Dec 31, 2019 | $55.80M | – |
See a number that looks wrong?